• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白在帕金森病中对神经元和神经胶质损伤的贡献。

Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease.

机构信息

Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, 92-215 Lodz, Poland.

出版信息

Int J Mol Sci. 2023 Dec 26;25(1):360. doi: 10.3390/ijms25010360.

DOI:10.3390/ijms25010360
PMID:38203531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10778752/
Abstract

Parkinson's disease (PD) is a complex neurodegenerative disease characterized by the progressive loss of dopaminergic neurons in the substantia nigra and the widespread accumulation of alpha-synuclein (αSyn) protein aggregates. αSyn aggregation disrupts critical cellular processes, including synaptic function, mitochondrial integrity, and proteostasis, which culminate in neuronal cell death. Importantly, αSyn pathology extends beyond neurons-it also encompasses spreading throughout the neuronal environment and internalization by microglia and astrocytes. Once internalized, glia can act as neuroprotective scavengers, which limit the spread of αSyn. However, they can also become reactive, thereby contributing to neuroinflammation and the progression of PD. Recent advances in αSyn research have enabled the molecular diagnosis of PD and accelerated the development of targeted therapies. Nevertheless, despite more than two decades of research, the cellular function, aggregation mechanisms, and induction of cellular damage by αSyn remain incompletely understood. Unraveling the interplay between αSyn, neurons, and glia may provide insights into disease initiation and progression, which may bring us closer to exploring new effective therapeutic strategies. Herein, we provide an overview of recent studies emphasizing the multifaceted nature of αSyn and its impact on both neuron and glial cell damage.

摘要

帕金森病(PD)是一种复杂的神经退行性疾病,其特征是黑质中多巴胺能神经元的进行性丧失和广泛积累的α-突触核蛋白(αSyn)蛋白聚集体。αSyn 聚集破坏了关键的细胞过程,包括突触功能、线粒体完整性和蛋白质稳态,最终导致神经元细胞死亡。重要的是,αSyn 病理学不仅局限于神经元 - 它还包括在神经元环境中的扩散以及被小胶质细胞和星形胶质细胞内化。一旦内化,胶质细胞可以作为神经保护的清道夫,限制αSyn 的扩散。然而,它们也可以变得反应性,从而导致神经炎症和 PD 的进展。αSyn 研究的最新进展使 PD 的分子诊断成为可能,并加速了靶向治疗的发展。然而,尽管经过了二十多年的研究,αSyn 的细胞功能、聚集机制以及对细胞损伤的诱导仍然不完全清楚。揭示αSyn、神经元和胶质细胞之间的相互作用可能为疾病的发生和进展提供深入的了解,从而使我们更接近探索新的有效治疗策略。本文提供了对最近研究的概述,强调了αSyn 的多面性及其对神经元和神经胶质细胞损伤的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29be/10778752/9decdb640f21/ijms-25-00360-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29be/10778752/5b743a008f3e/ijms-25-00360-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29be/10778752/9decdb640f21/ijms-25-00360-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29be/10778752/5b743a008f3e/ijms-25-00360-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29be/10778752/9decdb640f21/ijms-25-00360-g002.jpg

相似文献

1
Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease.α-突触核蛋白在帕金森病中对神经元和神经胶质损伤的贡献。
Int J Mol Sci. 2023 Dec 26;25(1):360. doi: 10.3390/ijms25010360.
2
α-Synuclein Oligomers Induce Glutamate Release from Astrocytes and Excessive Extrasynaptic NMDAR Activity in Neurons, Thus Contributing to Synapse Loss.α-突触核蛋白寡聚体诱导星形胶质细胞释放谷氨酸,并导致神经元过度的突触外 NMDA 受体活性,从而导致突触丢失。
J Neurosci. 2021 Mar 10;41(10):2264-2273. doi: 10.1523/JNEUROSCI.1871-20.2020. Epub 2021 Jan 22.
3
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.MHC 类 II 转录激活因子调节帕金森病体内大鼠模型中种子化的α-突触核蛋白病理和多巴胺能神经退行性变。
Brain Behav Immun. 2021 Jan;91:369-382. doi: 10.1016/j.bbi.2020.10.017. Epub 2020 Oct 22.
4
14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.14-3-3 蛋白减少致病性 α-突触核蛋白的细胞间转移和传播。
J Neurosci. 2018 Sep 19;38(38):8211-8232. doi: 10.1523/JNEUROSCI.1134-18.2018. Epub 2018 Aug 9.
5
Neuropathology of α-synuclein in Parkinson's disease.帕金森病中α-突触核蛋白的神经病理学。
Neuropathology. 2022 Apr;42(2):93-103. doi: 10.1111/neup.12812. Epub 2022 Mar 31.
6
Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.通过向黑质内注射预先形成的人源α-突触核蛋白寡聚体来模拟帕金森病神经病理学和症状。
Int J Mol Sci. 2020 Nov 12;21(22):8535. doi: 10.3390/ijms21228535.
7
Parkinson's disease risk genes act in glia to control neuronal α-synuclein toxicity.帕金森病风险基因在神经胶质细胞中发挥作用,以控制神经元α-突触核蛋白毒性。
Neurobiol Dis. 2021 Nov;159:105482. doi: 10.1016/j.nbd.2021.105482. Epub 2021 Aug 11.
8
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson's disease.半乳糖凝集素-3 塑造帕金森病中的毒性α-突触核蛋白菌株。
Acta Neuropathol. 2023 Jul;146(1):51-75. doi: 10.1007/s00401-023-02585-x. Epub 2023 May 18.
9
Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.人类髓过氧化物酶(hMPO)在帕金森病的黑质神经元中表达,也在 hMPO-α-突触核蛋白-A53T 小鼠模型中表达,与α-突触核蛋白的硝化和聚集增加以及运动障碍恶化相关。
Free Radic Biol Med. 2019 Sep;141:115-140. doi: 10.1016/j.freeradbiomed.2019.05.033. Epub 2019 Jun 6.
10
Alpha-synuclein suppresses mitochondrial protease ClpP to trigger mitochondrial oxidative damage and neurotoxicity.α-突触核蛋白抑制线粒体蛋白酶 ClpP 以触发线粒体氧化损伤和神经毒性。
Acta Neuropathol. 2019 Jun;137(6):939-960. doi: 10.1007/s00401-019-01993-2. Epub 2019 Mar 15.

引用本文的文献

1
Activity and Heterogeneity of Astrocytes in Neurological Diseases: Molecular Mechanisms and Therapeutic Targets.神经疾病中星形胶质细胞的活性与异质性:分子机制与治疗靶点
MedComm (2020). 2025 Aug 22;6(9):e70329. doi: 10.1002/mco2.70329. eCollection 2025 Sep.
2
Levodopa and Plant-Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives.帕金森病中的左旋多巴与植物源生物活性化合物:作用机制、疗效及未来展望
CNS Neurosci Ther. 2025 Aug;31(8):e70540. doi: 10.1111/cns.70540.
3
The Redox Revolution in Brain Medicine: Targeting Oxidative Stress with AI, Multi-Omics and Mitochondrial Therapies for the Precision Eradication of Neurodegeneration.

本文引用的文献

1
Extracellular high molecular weight α-synuclein oligomers induce cell death by disrupting the plasma membrane.细胞外高分子量α-突触核蛋白寡聚体通过破坏质膜诱导细胞死亡。
NPJ Parkinsons Dis. 2023 Sep 28;9(1):139. doi: 10.1038/s41531-023-00583-0.
2
Changes in oligodendroglial subpopulations in Parkinson's disease.帕金森病中少突胶质细胞亚群的变化。
Mol Brain. 2023 Sep 14;16(1):65. doi: 10.1186/s13041-023-01055-5.
3
Specialized astrocytes mediate glutamatergic gliotransmission in the CNS.特化星形胶质细胞介导中枢神经系统中的谷氨酸能神经胶质传递。
脑医学中的氧化还原革命:利用人工智能、多组学和线粒体疗法靶向氧化应激以精准根除神经退行性变
Int J Mol Sci. 2025 Aug 3;26(15):7498. doi: 10.3390/ijms26157498.
4
Exosomes from high-altitude cerebral edema patients induce cognitive dysfunction by altering oxidative stress responses in mice.来自高原脑水肿患者的外泌体通过改变小鼠的氧化应激反应诱导认知功能障碍。
Transl Psychiatry. 2025 Jul 22;15(1):253. doi: 10.1038/s41398-025-03469-2.
5
Pathological α-synuclein dysregulates epitranscriptomic writer METTL3 to drive neuroinflammation in microglia.病理性α-突触核蛋白失调表观转录组书写蛋白METTL3,以驱动小胶质细胞中的神经炎症。
Cell Rep. 2025 May 27;44(5):115618. doi: 10.1016/j.celrep.2025.115618. Epub 2025 Apr 23.
6
The interplay between α-synuclein aggregation and necroptosis in Parkinson's disease: a spatiotemporal perspective.帕金森病中α-突触核蛋白聚集与坏死性凋亡之间的相互作用:时空视角
Front Neurosci. 2025 Apr 8;19:1567445. doi: 10.3389/fnins.2025.1567445. eCollection 2025.
7
Inspecting the Triazole Scaffold as Powerful Antifibril Agents against 2N4R Tau and α-Synuclein Aggregates.将三唑支架作为针对2N4R Tau和α-突触核蛋白聚集体的强效抗纤维化剂进行研究。
ACS Omega. 2025 Feb 12;10(7):6721-6734. doi: 10.1021/acsomega.4c08385. eCollection 2025 Feb 25.
8
Therapeutic exploration potential of adenosine receptor antagonists through pharmacophore ligand-based modelling and pharmacokinetics studies against Parkinson disease.通过基于药效团配体的建模和针对帕金森病的药代动力学研究探索腺苷受体拮抗剂的治疗潜力。
In Silico Pharmacol. 2025 Jan 25;13(1):17. doi: 10.1007/s40203-025-00305-9. eCollection 2025.
9
Role of Oxidative Stress in Blood-Brain Barrier Disruption and Neurodegenerative Diseases.氧化应激在血脑屏障破坏和神经退行性疾病中的作用
Antioxidants (Basel). 2024 Nov 28;13(12):1462. doi: 10.3390/antiox13121462.
10
α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation.α-突触核蛋白种子扩增检测在突触核蛋白病诊断中的应用:临床实施中的创新工具。
Transl Neurodegener. 2024 Nov 21;13(1):56. doi: 10.1186/s40035-024-00449-2.
Nature. 2023 Oct;622(7981):120-129. doi: 10.1038/s41586-023-06502-w. Epub 2023 Sep 6.
4
Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy.抑制蛋白质聚集和内质网应激作为α-突触核蛋白病的靶向治疗方法。
Pharmaceutics. 2023 Jul 30;15(8):2051. doi: 10.3390/pharmaceutics15082051.
5
Molecular Mechanisms Underlying NMDARs Dysfunction and Their Role in ADHD Pathogenesis.NMDARs 功能障碍的分子机制及其在 ADHD 发病机制中的作用。
Int J Mol Sci. 2023 Aug 19;24(16):12983. doi: 10.3390/ijms241612983.
6
Animal models of Parkinson's disease: bridging the gap between disease hallmarks and research questions.帕金森病动物模型:弥合疾病特征与研究问题之间的差距。
Transl Neurodegener. 2023 Jul 19;12(1):36. doi: 10.1186/s40035-023-00368-8.
7
Identity, structure, and function of the mitochondrial permeability transition pore: controversies, consensus, recent advances, and future directions.线粒体通透性转换孔的身份、结构和功能:争议、共识、最新进展和未来方向。
Cell Death Differ. 2023 Aug;30(8):1869-1885. doi: 10.1038/s41418-023-01187-0. Epub 2023 Jul 17.
8
Role of neuroinflammation in neurodegeneration development.神经炎症在神经退行性变发展中的作用。
Signal Transduct Target Ther. 2023 Jul 12;8(1):267. doi: 10.1038/s41392-023-01486-5.
9
Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson's iPSC-dopamine neurons.钙调节异常、线粒体功能障碍和电生理成熟共同作用于帕金森病患者的诱导多能干细胞来源的多巴胺能神经元。
iScience. 2023 Jun 7;26(7):107044. doi: 10.1016/j.isci.2023.107044. eCollection 2023 Jul 21.
10
Autophagy‑regulating miRNAs: Novel therapeutic targets for Parkinson's disease (Review).自噬调控 miRNA:帕金森病的新型治疗靶点(综述)。
Int J Mol Med. 2023 Jun;51(6). doi: 10.3892/ijmm.2023.5253. Epub 2023 May 5.